Read More Pharma Industry News Inovio Pharmaceuticals faces tumultuous stock reaction to $30m offering Inovio Pharmaceuticals, a biotechnology company specialising in DNA medicines, witnessed a sharp decline in its stock value following… byPallavi MadhirajuDecember 14, 2024